Source:http://linkedlifedata.com/resource/pubmed/id/12377279
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2002-10-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1471-4922
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
344
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12377279-Animals,
pubmed-meshheading:12377279-Antimalarials,
pubmed-meshheading:12377279-Chlorpromazine,
pubmed-meshheading:12377279-Drug Resistance,
pubmed-meshheading:12377279-Hemin,
pubmed-meshheading:12377279-Humans,
pubmed-meshheading:12377279-Malaria, Falciparum,
pubmed-meshheading:12377279-Parasitic Sensitivity Tests,
pubmed-meshheading:12377279-Plasmodium falciparum
|
pubmed:year |
2002
|
pubmed:articleTitle |
Turning a chloroquine-resistance reverser into an antimalarial.
|
pubmed:publicationType |
News
|